17.00-18.30     CAPITAL SUITE 14/15/16     

Prognosis and therapy of diabetic nephropathy: one size does not fit them all (SYSKID)
Chairs: Gert Mayer, Innsbruck, Austria
             Rainer Oberbauer, Vienna, Austria

The epidemiology of CKD in Europe: implications for healthcare policies
Kitty J. Jager, Amsterdam, The Netherlands
Clinical utility of risk scores/biomarkers to predict progression and outcome in diabetic nephropathy
Peter Rossing, Gentofte, Denmark
Linking biomarkers to pathophysiology and treatment response: a systems biology approach
Bernd Mayer, Vienna, Austria
Enrichment strategies in clinical trials - the road to personalized medicine in nephrology?
Dick De Zeeuw, Groningen, The Netherlands


back to the timetable